Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Saturday, 27 April 2024
Accelrys Inc.
NASDAQ
ACCL
Summary
|
Chart
|
News
|
History
|
More info..
NASDAQ : ACCL
12.51
29 Apr 14 00:00
Change:
0.03
Open:
12.49
High:
12.51
Ask:
6.57
Volume:
408,000
Change(%):
0.24
Prev:
12.48
Low:
12.48
Bid:
5.70
Avg vol:
0
Latest News
More news...
Pharmplanet became a top-five among pharmaceutical distributors in Ukraine
04:45 | 15/10/14
PharmiWeb.com
Pharmplanet today is the leader in terms of sales growth in the wholesale pharmaceutical market, as evidenced by the increase in sales + 88.3% in the first half of 2014 compared to the same period of 2013.
more»
North America Bronchoscopes Market Outlook to 2020
07:56 | 30/9/14
PharmiWeb.com
2013 company shares and distribution shares data for Bronchoscopes market.- Global corporate-level profiles of key companies operating within the North America Bronchoscopes market.
more»
NIH Funds to Tackle Sex Bias in Research
15:56 | 26/9/14
Lab Manager Laboratory News
Lab Manager · Facebook Analytical Chemistry Techniques · Facebook Cell Culture Techniques · Facebook Environmental Science Techniques · Facebook Food & Nutrition Science · Facebook Laboratory Products & Equipment.
more»
SafeWire Inc. Announces US Launch of the Tiger™ Pedicle Access Needle Family
00:56 | 25/9/14
PharmiWeb.com
COOPER CITY Fla. Sept. 24 2014 /PRNewswire-iReach/ -- SafeWire Inc. a medical device company focused on improving minimally invasive spine surgery announced today the introduction of its Tiger™ Pedicle Access Needle family.
more»
Exenatide treatment also results in greater treatment satisfaction and ...
00:33 | 25/9/14
PharmiWeb.com
“The results of this study demonstrate that, on a background of basal insulin, exenatide twice-daily is as effective as bolus insulin in improving blood glucose levels.
more»
Comments
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
REGISTER NOW
If you are already registered, please
LOGIN NOW
Add to Watchlist
Add to Portfolio
Add Email Alert
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
Most Viewed Stories
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%
Newsletters
Email Address:
Weekly Newsletter
Daily Market Report
Daily Forex Report
Daily Global Report